Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul 25;7(14):3683-3685.
doi: 10.1182/bloodadvances.2023009723.

The value of the old and the new

Affiliations
Comment

The value of the old and the new

Paul Monagle et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: P.M. reports membership of steering committees for EINSTEIN-Jr (Rivaroxaban) and SAXOPHONE (Apixaban) studies, and unpaid advisory board participation for Takeda, Bayer, and Janssen. C.M. reports fees to the institution for study participation from Bayer, Bristol Myers Squibb, and Pfizer; personal honoraria (consultancy, speaker, and chair) from Anthos, Bayer, Chiesi, Janssen, and Norgine; and membership in Pediatric Antithrombotic Trials Leadership and Steering (Pedi-ATLAS) Group (no payments), for the past 3 years. L.R. reports participation in advisory boards for Boeringer Ingelheim, Genentech, and Jannsen.

Comment on

References

    1. Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2(22):3292–3316. - PMC - PubMed
    1. Mustafa RA, Garcia CAC, Bhatt M, et al. GRADE notes: how to use GRADE when there is "no" evidence? A case study of the expert evidence approach. J Clin Epidemiol. 2021;137:231–235. - PubMed
    1. Wiercioch W, Nieuwlaat R, Akl EA, et al. Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv. 2020;4(10):2351–2365. - PMC - PubMed
    1. Nieuwlaat R, Wiercioch W, Brozek JL, et al. How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines. Blood Adv. 2021;5(22):4721–4726. - PMC - PubMed
    1. Kubitza D, Willmann S, Becka M, et al. Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study. Thromb J. 2018;16:31. - PMC - PubMed

LinkOut - more resources